ID   PLD3_HUMAN              Reviewed;         490 AA.
AC   Q8IV08; Q92853; Q9BW87;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   10-MAY-2017, entry version 125.
DE   RecName: Full=Phospholipase D3;
DE            Short=PLD 3;
DE            EC=3.1.4.4;
DE   AltName: Full=Choline phosphatase 3;
DE   AltName: Full=HindIII K4L homolog;
DE   AltName: Full=Hu-K4;
DE   AltName: Full=Phosphatidylcholine-hydrolyzing phospholipase D3;
GN   Name=PLD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=9140189; DOI=10.1016/S0168-1702(96)01422-0;
RA   Cao J.X., Koop B.F., Upton C.;
RT   "A human homolog of the vaccinia virus HindIII K4L gene is a member of
RT   the phospholipase D superfamily.";
RL   Virus Res. 48:11-18(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION, TOPOLOGY, TISSUE SPECIFICITY, AND GLYCOSYLATION.
RX   PubMed=15794758; DOI=10.1111/j.1742-4658.2005.04601.x;
RA   Munck A., Boehm C., Seibel N.M., Hashemol Hosseini Z., Hampe W.;
RT   "Hu-K4 is a ubiquitously expressed type 2 transmembrane protein
RT   associated with the endoplasmic reticulum.";
RL   FEBS J. 272:1718-1726(2005).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-97 AND ASN-132.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   FUNCTION, POSSIBLE INVOLVEMENT IN ALZHEIMER DISEASE, VARIANT MET-232,
RP   TISSUE SPECIFICITY, AND INTERACTION WITH APP.
RX   PubMed=24336208; DOI=10.1038/nature12825;
RG   UK Brain Expression Consortium;
RA   Cruchaga C., Karch C.M., Jin S.C., Benitez B.A., Cai Y., Guerreiro R.,
RA   Harari O., Norton J., Budde J., Bertelsen S., Jeng A.T., Cooper B.,
RA   Skorupa T., Carrell D., Levitch D., Hsu S., Choi J., Ryten M.,
RA   Hardy J., Ryten M., Trabzuni D., Weale M.E., Ramasamy A., Smith C.,
RA   Sassi C., Bras J., Gibbs J.R., Hernandez D.G., Lupton M.K., Powell J.,
RA   Forabosco P., Ridge P.G., Corcoran C.D., Tschanz J.T., Norton M.C.,
RA   Munger R.G., Schmutz C., Leary M., Demirci F.Y., Bamne M.N., Wang X.,
RA   Lopez O.L., Ganguli M., Medway C., Turton J., Lord J., Braae A.,
RA   Barber I., Brown K., Passmore P., Craig D., Johnston J.,
RA   McGuinness B., Todd S., Heun R., Kolsch H., Kehoe P.G., Hooper N.M.,
RA   Vardy E.R., Mann D.M., Pickering-Brown S., Brown K., Kalsheker N.,
RA   Lowe J., Morgan K., David Smith A., Wilcock G., Warden D., Holmes C.,
RA   Pastor P., Lorenzo-Betancor O., Brkanac Z., Scott E., Topol E.,
RA   Morgan K., Rogaeva E., Singleton A.B., Hardy J., Kamboh M.I.,
RA   St George-Hyslop P., Cairns N., Morris J.C., Kauwe J.S., Goate A.M.;
RT   "Rare coding variants in the phospholipase D3 gene confer risk for
RT   Alzheimer's disease.";
RL   Nature 505:550-554(2014).
RN   [8]
RP   LACK OF INVOLVEMENT IN ALZHEIMER DISEASE, AND VARIANTS SER-63; ALA-76;
RP   MET-159; CYS-162; SER-173; GLY-175; CYS-188; HIS-222; MET-232;
RP   GLN-242; GLY-249; CYS-272; SER-284; VAL-293; LEU-297; TYR-300;
RP   PRO-308; ILE-358; ALA-426 AND ARG-429.
RX   PubMed=26411346; DOI=10.1002/humu.22908;
RG   Belgium Neurology (BELNEU) Consortium and the European Early-Onset Dementia (EU EOD) Consortium;
RA   Cacace R., Van den Bossche T., Engelborghs S., Geerts N., Laureys A.,
RA   Dillen L., Graff C., Thonberg H., Chiang H.H., Pastor P.,
RA   Ortega-Cubero S., Pastor M.A., Diehl-Schmid J., Alexopoulos P.,
RA   Benussi L., Ghidoni R., Binetti G., Nacmias B., Sorbi S.,
RA   Sanchez-Valle R., Llado A., Gelpi E., Almeida M.R., Santana I.,
RA   Tsolaki M., Koutroumani M., Clarimon J., Lleo A., Fortea J.,
RA   de Mendonca A., Martins M., Borroni B., Padovani A., Matej R.,
RA   Rohan Z., Vandenbulcke M., Vandenberghe R., De Deyn P.P., Cras P.,
RA   van der Zee J., Sleegers K., Van Broeckhoven C.;
RT   "Rare variants in PLD3 do not affect risk for early-onset Alzheimer
RT   disease in a European consortium cohort.";
RL   Hum. Mutat. 36:1226-1235(2015).
RN   [9]
RP   LACK OF INVOLVEMENT IN ALZHEIMER DISEASE.
RX   PubMed=25832408; DOI=10.1038/nature14036;
RA   Lambert J.C., Grenier-Boley B., Bellenguez C., Pasquier F.,
RA   Campion D., Dartigues J.F., Berr C., Tzourio C., Amouyel P.;
RT   "PLD3 and sporadic Alzheimer's disease risk.";
RL   Nature 520:E1-E1(2015).
RN   [10]
RP   LACK OF INVOLVEMENT IN ALZHEIMER DISEASE, AND VARIANT MET-232.
RX   PubMed=25832410; DOI=10.1038/nature14038;
RA   van der Lee S.J., Holstege H., Wong T.H., Jakobsdottir J., Bis J.C.,
RA   Chouraki V., van Rooij J.G., Grove M.L., Smith A.V., Amin N.,
RA   Choi S.H., Beiser A.S., Garcia M.E., van Ijcken W.F., Pijnenburg Y.A.,
RA   Louwersheimer E., Brouwer R.W., van den Hout M.C., Oole E.,
RA   Eirkisdottir G., Levy D., Rotter J.I., Emilsson V., O'Donnell C.J.,
RA   Aspelund T., Uitterlinden A.G., Launer L.J., Hofman A., Boerwinkle E.,
RA   Psaty B.M., DeStefano A.L., Scheltens P., Seshadri S.,
RA   van Swieten J.C., Gudnason V., van der Flier W.M., Ikram M.A.,
RA   van Duijn C.M.;
RT   "PLD3 variants in population studies.";
RL   Nature 520:E2-E3(2015).
RN   [11]
RP   LACK OF INVOLVEMENT IN ALZHEIMER DISEASE, AND VARIANT MET-232.
RX   PubMed=25832411; DOI=10.1038/nature14039;
RA   Heilmann S., Drichel D., Clarimon J., Fernandez V., Lacour A.,
RA   Wagner H., Thelen M., Hernandez I., Fortea J., Alegret M., Blesa R.,
RA   Mauleon A., Roca M.R., Kornhuber J., Peters O., Heun R., Froelich L.,
RA   Huell M., Heneka M.T., Ruether E., Riedel-Heller S., Scherer M.,
RA   Wiltfang J., Jessen F., Becker T., Tarraga L., Boada M., Maier W.,
RA   Lleo A., Ruiz A., Noethen M.M., Ramirez A.;
RT   "PLD3 in non-familial Alzheimer's disease.";
RL   Nature 520:E3-E5(2015).
RN   [12]
RP   LACK OF INVOLVEMENT IN ALZHEIMER DISEASE.
RX   PubMed=25832413; DOI=10.1038/nature14040;
RA   Hooli B.V., Lill C.M., Mullin K., Qiao D., Lange C., Bertram L.,
RA   Tanzi R.E.;
RT   "PLD3 gene variants and Alzheimer's disease.";
RL   Nature 520:E7-E8(2015).
RN   [13]
RP   POSSIBLE INVOLVEMENT IN ALZHEIMER DISEASE.
RX   PubMed=25832409; DOI=10.1038/nature14041;
RA   Cruchaga C., Goate A.M.;
RT   "Cruchaga & Goate reply.";
RL   Nature 520:E10-E10(2015).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: May be involved in APP processing.
CC       {ECO:0000305|PubMed:24336208}.
CC   -!- CATALYTIC ACTIVITY: A phosphatidylcholine + H(2)O = choline + a
CC       phosphatidate.
CC   -!- SUBUNIT: Interacts with APP. {ECO:0000269|PubMed:24336208}.
CC   -!- INTERACTION:
CC       P19838:NFKB1; NbExp=2; IntAct=EBI-2689908, EBI-300010;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15794758}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:15794758}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. In the brain, high levels of
CC       expression are detected in the frontal, temporal and occipital
CC       cortices and hippocampus. Expressed at low level in corpus
CC       callosum. {ECO:0000269|PubMed:15794758,
CC       ECO:0000269|PubMed:24336208}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:15794758,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- DISEASE: Note=Genetic variants in PLD3 have been suggested to be
CC       associated with an increased risk for Alzheimer disease
CC       (PubMed:24336208, PubMed:25832409). Further studies, however, did
CC       not support PLD3 involvement in this disease (PubMed:25832408,
CC       PubMed:25832411, PubMed:25832413, PubMed:25832410,
CC       PubMed:26411346). {ECO:0000269|PubMed:24336208,
CC       ECO:0000269|PubMed:25832408, ECO:0000269|PubMed:25832409,
CC       ECO:0000269|PubMed:25832410, ECO:0000269|PubMed:25832411,
CC       ECO:0000269|PubMed:25832413, ECO:0000269|PubMed:26411346}.
CC   -!- SIMILARITY: Belongs to the phospholipase D family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB16799.1; Type=Frameshift; Positions=52; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U60644; AAB16799.1; ALT_FRAME; mRNA.
DR   EMBL; BC000553; AAH00553.2; -; mRNA.
DR   EMBL; BC036327; AAH36327.1; -; mRNA.
DR   EMBL; BC096820; AAH96820.1; -; mRNA.
DR   CCDS; CCDS33027.1; -.
DR   RefSeq; NP_001026866.1; NM_001031696.3.
DR   RefSeq; NP_001278240.1; NM_001291311.1.
DR   RefSeq; NP_036400.2; NM_012268.3.
DR   RefSeq; XP_005258761.1; XM_005258704.1.
DR   RefSeq; XP_005258764.1; XM_005258707.4.
DR   RefSeq; XP_005258765.1; XM_005258708.3.
DR   RefSeq; XP_005258766.1; XM_005258709.4.
DR   RefSeq; XP_005258767.1; XM_005258710.4.
DR   RefSeq; XP_006723185.1; XM_006723122.1.
DR   RefSeq; XP_011524994.1; XM_011526692.1.
DR   RefSeq; XP_011524995.1; XM_011526693.1.
DR   RefSeq; XP_016882035.1; XM_017026546.1.
DR   RefSeq; XP_016882036.1; XM_017026547.1.
DR   RefSeq; XP_016882037.1; XM_017026548.1.
DR   RefSeq; XP_016882038.1; XM_017026549.1.
DR   UniGene; Hs.257008; -.
DR   ProteinModelPortal; Q8IV08; -.
DR   SMR; Q8IV08; -.
DR   BioGrid; 117173; 24.
DR   IntAct; Q8IV08; 24.
DR   STRING; 9606.ENSP00000348901; -.
DR   iPTMnet; Q8IV08; -.
DR   PhosphoSitePlus; Q8IV08; -.
DR   BioMuta; PLD3; -.
DR   DMDM; 74750647; -.
DR   EPD; Q8IV08; -.
DR   MaxQB; Q8IV08; -.
DR   PaxDb; Q8IV08; -.
DR   PeptideAtlas; Q8IV08; -.
DR   PRIDE; Q8IV08; -.
DR   TopDownProteomics; Q8IV08; -.
DR   DNASU; 23646; -.
DR   Ensembl; ENST00000356508; ENSP00000348901; ENSG00000105223.
DR   Ensembl; ENST00000409281; ENSP00000387022; ENSG00000105223.
DR   Ensembl; ENST00000409419; ENSP00000386293; ENSG00000105223.
DR   Ensembl; ENST00000409587; ENSP00000387050; ENSG00000105223.
DR   Ensembl; ENST00000409735; ENSP00000386938; ENSG00000105223.
DR   GeneID; 23646; -.
DR   KEGG; hsa:23646; -.
DR   UCSC; uc002onj.5; human.
DR   CTD; 23646; -.
DR   DisGeNET; 23646; -.
DR   GeneCards; PLD3; -.
DR   HGNC; HGNC:17158; PLD3.
DR   HPA; CAB020812; -.
DR   HPA; HPA012800; -.
DR   MalaCards; PLD3; -.
DR   MIM; 615698; gene.
DR   neXtProt; NX_Q8IV08; -.
DR   OpenTargets; ENSG00000105223; -.
DR   PharmGKB; PA134887482; -.
DR   eggNOG; KOG3603; Eukaryota.
DR   eggNOG; ENOG410XQZ4; LUCA.
DR   GeneTree; ENSGT00390000009798; -.
DR   HOGENOM; HOG000293407; -.
DR   HOVERGEN; HBG052880; -.
DR   InParanoid; Q8IV08; -.
DR   KO; K16860; -.
DR   OMA; GVYPDYT; -.
DR   OrthoDB; EOG091G07LR; -.
DR   PhylomeDB; Q8IV08; -.
DR   TreeFam; TF313378; -.
DR   Reactome; R-HSA-1483148; Synthesis of PG.
DR   Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
DR   ChiTaRS; PLD3; human.
DR   GenomeRNAi; 23646; -.
DR   PRO; PR:Q8IV08; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105223; -.
DR   CleanEx; HS_PLD3; -.
DR   ExpressionAtlas; Q8IV08; baseline and differential.
DR   Genevisible; Q8IV08; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0070290; F:N-acylphosphatidylethanolamine-specific phospholipase D activity; IEA:UniProtKB-EC.
DR   GO; GO:0004630; F:phospholipase D activity; TAS:ProtInc.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   InterPro; IPR032803; PLDc_3.
DR   InterPro; IPR001736; PLipase_D/transphosphatidylase.
DR   Pfam; PF00614; PLDc; 1.
DR   Pfam; PF13918; PLDc_3; 1.
DR   SMART; SM00155; PLDc; 2.
DR   PROSITE; PS50035; PLD; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Membrane; Polymorphism;
KW   Reference proteome; Repeat; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    490       Phospholipase D3.
FT                                /FTId=PRO_0000280326.
FT   TOPO_DOM      1     38       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     39     59       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     60    490       Lumenal. {ECO:0000255}.
FT   DOMAIN      196    223       PLD phosphodiesterase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   DOMAIN      411    437       PLD phosphodiesterase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   ACT_SITE    201    201       {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   ACT_SITE    203    203       {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   ACT_SITE    208    208       {ECO:0000255|PROSITE-ProRule:PRU00153}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    132    132       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VARIANT      63     63       G -> S (in dbSNP:rs142070038).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075905.
FT   VARIANT      76     76       P -> A (in dbSNP:rs138674695).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075906.
FT   VARIANT     159    159       V -> M (in dbSNP:rs374184677).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075907.
FT   VARIANT     162    162       R -> C. {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075908.
FT   VARIANT     173    173       P -> S. {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075909.
FT   VARIANT     175    175       A -> G. {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075910.
FT   VARIANT     188    188       R -> C. {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075911.
FT   VARIANT     222    222       R -> H (in dbSNP:rs765630414).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075912.
FT   VARIANT     232    232       V -> M (found in Alzheimer disease
FT                                patients at higher frequency compared to
FT                                controls; unknown pathological
FT                                significance; dbSNP:rs145999145).
FT                                {ECO:0000269|PubMed:24336208,
FT                                ECO:0000269|PubMed:25832410,
FT                                ECO:0000269|PubMed:25832411,
FT                                ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_071186.
FT   VARIANT     242    242       R -> Q (in dbSNP:rs757965784).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075913.
FT   VARIANT     249    249       E -> G (in dbSNP:rs746715924).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075914.
FT   VARIANT     272    272       R -> C (in dbSNP:rs144312764).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075915.
FT   VARIANT     284    284       N -> S (in dbSNP:rs200274020).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075916.
FT   VARIANT     293    293       A -> V (in dbSNP:rs368737000).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075917.
FT   VARIANT     297    297       P -> L. {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075918.
FT   VARIANT     300    300       C -> Y (in dbSNP:rs146083475).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075919.
FT   VARIANT     308    308       L -> P (in dbSNP:rs537053537).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075920.
FT   VARIANT     358    358       V -> I (in dbSNP:rs370488565).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075921.
FT   VARIANT     426    426       T -> A (in dbSNP:rs745463234).
FT                                {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075922.
FT   VARIANT     429    429       G -> R. {ECO:0000269|PubMed:26411346}.
FT                                /FTId=VAR_075923.
FT   CONFLICT    473    473       S -> I (in Ref. 1; AAB16799).
FT                                {ECO:0000305}.
SQ   SEQUENCE   490 AA;  54705 MW;  444EC4D02F5610F1 CRC64;
     MKPKLMYQEL KVPAEEPANE LPMNEIEAWK AAEKKARWVL LVLILAVVGF GALMTQLFLW
     EYGDLHLFGP NQRPAPCYDP CEAVLVESIP EGLDFPNAST GNPSTSQAWL GLLAGAHSSL
     DIASFYWTLT NNDTHTQEPS AQQGEEVLRQ LQTLAPKGVN VRIAVSKPSG PQPQADLQAL
     LQSGAQVRMV DMQKLTHGVL HTKFWVVDQT HFYLGSANMD WRSLTQVKEL GVVMYNCSCL
     ARDLTKIFEA YWFLGQAGSS IPSTWPRFYD TRYNQETPME ICLNGTPALA YLASAPPPLC
     PSGRTPDLKA LLNVVDNARS FIYVAVMNYL PTLEFSHPHR FWPAIDDGLR RATYERGVKV
     RLLISCWGHS EPSMRAFLLS LAALRDNHTH SDIQVKLFVV PADEAQARIP YARVNHNKYM
     VTERATYIGT SNWSGNYFTE TAGTSLLVTQ NGRGGLRSQL EAIFLRDWDS PYSHDLDTSA
     DSVGNACRLL
//
